Received: 14 July 2020
Accepted: 12 October 2020
First Online: 19 October 2020
Ethics approval and consent to participate
: The study was approved by Hamad Medical Corporation’s Institutional Review Board (MRC0120191), with a waiver of informed consent. No additional administrative permissions were required to access the raw data. All data used in this study were anonymized before their use.
: Not applicable.
: The authors declare that they have no competing interests.